论文部分内容阅读
至今,肝门胆管癌仍是一种极具挑战性的腹部恶性肿瘤。虽根治性切除可使患者获长期生存希望,然而在我国的切除率仅在10%~20%。内、外引流减黄术仍为晚期患者主要的治疗手段。自1992年1月~1998年1月我们通过胆肠桥式吻合治疗晚期肝门胆管癌22例。结果显示此术式简单、实用,减黄
To date, hilar cholangiocarcinoma is still a very challenging abdominal malignancy. Although radical resection can provide long-term survival for patients, the resection rate in China is only 10% to 20%. Intra-arterial and external drainage yellow reduction is still the main treatment for advanced patients. From January 1992 to January 1998, we treated 22 patients with advanced hilar cholangiocarcinoma by cholecystectomy. The results show that this method is simple, practical, yellowing